person

Marcus D.

Country
Germany
Department
Klinik und Poliklinik für Innere Medizin B

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 13 partner sites.

Specializations

Cardiomyopathy Management

Specializes in investigating therapeutic approaches for Transthyretin Amyloid Cardiomyopathy (ATTR-CM), focusing on advanced treatment options for adult patients. The investigator's work extends to studying virus-negative inflammatory cardiomyopathy, particularly in cases with compromised left ventricular function.

  • ATTR-CM therapeutics
  • Inflammatory cardiomyopathy treatment
  • Heart failure management

Explores innovative therapeutic strategies for patients with persistent cardiac dysfunction despite standard treatments.

Cardiovascular Disease

Conducts research in acute coronary syndrome and its complications, with particular attention to preventing recurrent cardiovascular events in post-heart attack patients. The investigator evaluates novel therapeutic agents for cardiovascular risk reduction.

  • Post-myocardial infarction care
  • Cardiovascular event prevention
  • Antithrombotic therapy

Focuses on developing enhanced treatment protocols for patients with acute cardiac conditions.

Clinical Therapeutics

Evaluates immunosuppressive treatments and novel pharmaceutical interventions in cardiac conditions. The investigator's work encompasses assessment of left ventricular ejection fraction and cardiac function markers.

  • Immunomodulatory therapy
  • Cardiac function assessment
  • Treatment optimization

Investigates the efficacy of various therapeutic approaches in complex cardiac conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.